Literature DB >> 26405609

Particulate β-glucan regulates the immunosuppression of granulocytic myeloid-derived suppressor cells by inhibiting NFIA expression.

Xinyu Tian1, Jie Tian2, Xinyi Tang2, Ke Rui2, Yue Zhang3, Jie Ma2, Yungang Wang2, Huaxi Xu2, Liwei Lu4, Shengjun Wang1.   

Abstract

Myeloid-derived suppressor cells (MDSCs) are a heterogeneous group of cells which comprise two subsets: granulocytic MDSCs (G-MDSCs) and monocytic MDSCs (M-MDSCs). MDSCs involve in tumor-associated immune suppression by remarkably blocking effector T-cell activation and inducing expansion of regulatory T cells in the tumor microenvironment. The treatment that alters the suppression of MDSCs can effectively facilitate the antitumor immune responses. Recently, we showed that the whole β-glucan particles (WGPs) are capable of altering the suppression of MDSCs. However, the regulatory mechanism of MDSCs by WGP remains unknown. In this study, we found that the expression of nuclear factor I-A (NFIA), an integral transcriptional component of myeloid differentiation and lineage commitment, was inhibited by WGP in G-MDSCs. The effect of WGP on expression of NFIA was the c-jun molecule dependent via Dectin-1 pathway in vitro. Moreover, NFIA knockdown could alter the suppressive function of G-MDSCs, promote the antitumor immune responses and delay the tumor progression in tumor-bearing mice. Taken together, our results demonstrate a critical role of NFIA during WGP regulating the immunosuppression of G-MDSCs, with potential implications as an antitumor immune therapeutic approach.

Entities:  

Keywords:  myeloid-derived suppressor cells; nuclear factor I-A; tumor immunology; β-glucan

Year:  2015        PMID: 26405609      PMCID: PMC4570107          DOI: 10.1080/2162402X.2015.1038687

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  35 in total

Review 1.  Roles of the NFI/CTF gene family in transcription and development.

Authors:  R M Gronostajski
Journal:  Gene       Date:  2000-05-16       Impact factor: 3.688

2.  Chemoprevention by cyclooxygenase-2 inhibition reduces immature myeloid suppressor cell expansion.

Authors:  James E Talmadge; Keith C Hood; Lori C Zobel; Laura R Shafer; Melissa Coles; Bela Toth
Journal:  Int Immunopharmacol       Date:  2006-10-24       Impact factor: 4.932

3.  Glucans from the edible mushroom Pleurotus pulmonarius inhibit colitis-associated colon carcinogenesis in mice.

Authors:  Iris Lavi; Lili Nimri; Dana Levinson; Irena Peri; Yitzhak Hadar; Betty Schwartz
Journal:  J Gastroenterol       Date:  2011-12-21       Impact factor: 7.527

4.  1,3-β-glucan affects the balance of Th1/Th2 cytokines by promoting secretion of anti-inflammatory cytokines in vitro.

Authors:  Ying Chen; Lei Dong; Dong Weng; Fangwei Liu; Laiyu Song; Cuiying Li; Wen Tang; Jie Chen
Journal:  Mol Med Rep       Date:  2013-06-25       Impact factor: 2.952

5.  Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived β-glucans.

Authors:  Chunjian Qi; Yihua Cai; Lacey Gunn; Chuanlin Ding; Bing Li; Goetz Kloecker; Keqing Qian; John Vasilakos; Shinobu Saijo; Yoichiro Iwakura; John R Yannelli; Jun Yan
Journal:  Blood       Date:  2011-04-29       Impact factor: 22.113

Review 6.  Beta-glucan recognition by the innate immune system.

Authors:  Helen S Goodridge; Andrea J Wolf; David M Underhill
Journal:  Immunol Rev       Date:  2009-07       Impact factor: 12.988

7.  Novel structural features in Candida albicans hyphal glucan provide a basis for differential innate immune recognition of hyphae versus yeast.

Authors:  Douglas W Lowman; Rachel R Greene; Daniel W Bearden; Michael D Kruppa; Max Pottier; Mario A Monteiro; Dmitriy V Soldatov; Harry E Ensley; Shih-Chin Cheng; Mihai G Netea; David L Williams
Journal:  J Biol Chem       Date:  2013-12-16       Impact factor: 5.157

8.  NFI-A directs the fate of hematopoietic progenitors to the erythroid or granulocytic lineage and controls beta-globin and G-CSF receptor expression.

Authors:  Linda Marie Starnes; Antonio Sorrentino; Elvira Pelosi; Monica Ballarino; Ornella Morsilli; Mauro Biffoni; Simona Santoro; Nadia Felli; Germana Castelli; Maria Laura De Marchis; Gianfranco Mastroberardino; Marco Gabbianelli; Alessandro Fatica; Irene Bozzoni; Clara Nervi; Cesare Peschle
Journal:  Blood       Date:  2009-06-19       Impact factor: 22.113

9.  The effects of orally administered Beta-glucan on innate immune responses in humans, a randomized open-label intervention pilot-study.

Authors:  Jenneke Leentjens; Jessica Quintin; Jelle Gerretsen; Matthijs Kox; Peter Pickkers; Mihai G Netea
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

10.  Stimulation of dendritic cells via the dectin-1/Syk pathway allows priming of cytotoxic T-cell responses.

Authors:  Salomé Leibundgut-Landmann; Fabiola Osorio; Gordon D Brown; Caetano Reis e Sousa
Journal:  Blood       Date:  2008-09-25       Impact factor: 22.113

View more
  10 in total

Review 1.  Recent advances in myeloid-derived suppressor cell biology.

Authors:  Mahmoud Mohammad Yaseen; Nizar Mohammad Abuharfeil; Homa Darmani; Ammar Daoud
Journal:  Front Med       Date:  2020-09-02       Impact factor: 4.592

2.  The novel α-glucan YCP improves the survival rates and symptoms in septic mice by regulating myeloid-derived suppressor cells.

Authors:  Dan Liu; Ming You; Guang-Feng Zhao; Xiu-Jun Li; Yu-Xian Song; Huan Dou; Wen-Bing Yao; Xiang-Dong Gao; Ya-Yi Hou
Journal:  Acta Pharmacol Sin       Date:  2017-06-26       Impact factor: 6.150

3.  IL-17A weakens the antitumor immuity by inhibiting apoptosis of MDSCs in Lewis lung carcinoma bearing mice.

Authors:  Juan Wang; Yue Zhang; Kai Yin; Peiqi Xu; Jie Tian; Jie Ma; Xinyu Tian; Yungang Wang; Xinyi Tang; Huaxi Xu; Shengjun Wang
Journal:  Oncotarget       Date:  2017-01-17

4.  Long Non-Coding RNA HOXA Transcript Antisense RNA Myeloid-Specific 1-HOXA1 Axis Downregulates the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells in Lung Cancer.

Authors:  Xinyu Tian; Jie Ma; Ting Wang; Jie Tian; Yue Zhang; Lingxiang Mao; Huaxi Xu; Shengjun Wang
Journal:  Front Immunol       Date:  2018-03-12       Impact factor: 7.561

5.  Long non-coding RNA RUNXOR accelerates MDSC-mediated immunosuppression in lung cancer.

Authors:  Xinyu Tian; Jie Ma; Ting Wang; Jie Tian; Yu Zheng; Rongrong Peng; Yungang Wang; Yue Zhang; Lingxiang Mao; Huaxi Xu; Shengjun Wang
Journal:  BMC Cancer       Date:  2018-06-18       Impact factor: 4.430

Review 6.  Long Non-coding RNAs as Communicators and Mediators Between the Tumor Microenvironment and Cancer Cells.

Authors:  Di Chen; Tong Lu; Junying Tan; Hao Li; Qiuyue Wang; Liangzhou Wei
Journal:  Front Oncol       Date:  2019-08-06       Impact factor: 6.244

Review 7.  Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer.

Authors:  Kai Li; Houhui Shi; Benxia Zhang; Xuejin Ou; Qizhi Ma; Yue Chen; Pei Shu; Dan Li; Yongsheng Wang
Journal:  Signal Transduct Target Ther       Date:  2021-10-07

8.  The downregulation of type I IFN signaling in G-MDSCs under tumor conditions promotes their development towards an immunosuppressive phenotype.

Authors:  Yingying Sun; Xiaoqing Han; Chao Shang; Yawei Wang; Boya Xu; Shu Jiang; Yan Mo; Dake Wang; Yueshuang Ke; Xianlu Zeng
Journal:  Cell Death Dis       Date:  2022-01-10       Impact factor: 8.469

9.  Exosomes released by granulocytic myeloid-derived suppressor cells attenuate DSS-induced colitis in mice.

Authors:  Yungang Wang; Jie Tian; Xinyi Tang; Ke Rui; Xinyu Tian; Jie Ma; Bin Ma; Huaxi Xu; Liwei Lu; Shengjun Wang
Journal:  Oncotarget       Date:  2016-03-29

10.  Mechanisms of immune suppression by myeloid-derived suppressor cells: the role of interleukin-10 as a key immunoregulatory cytokine.

Authors:  Mahmoud Mohammad Yaseen; Nizar Mohammad Abuharfeil; Homa Darmani; Ammar Daoud
Journal:  Open Biol       Date:  2020-09-16       Impact factor: 6.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.